Weight loss drugs are bringing down the country's obesity rate, a survey shows The number of people using injectable obesity treatments is increasing rapidly, and it is leading to declines in obesity, according to a new survey by the Gallup National Health and Well-Being Index
2014;12(7):10901100.e2
New medications entering clinical trials and approaching approval include triple agonists like retatrutide , combination therapies like CagriSema , oral formulations that eliminate the need for injections, and even transdermal GLP-1 patches
While categories such as salty snacks and candy are among those most likely to see a disproportionate reduction in consumption due to GLP-1s, users are additionally trading down in pack sizes in unexpected areas, including granola and coffee, according to Big Chalk
Por ejemplo, en ensayos clnicos, pacientes tratados con retatrutida lograron perder hasta un 24,2% de su peso corporal en solo 48 semanas
Photo Illustration by: Dr